Campbell Soup Valuation
Is CPB * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CPB * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CPB * (MX$774) is trading below our estimate of fair value (MX$1388.69)
Significantly Below Fair Value: CPB * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CPB *?
Other financial metrics that can be useful for relative valuation.
What is CPB *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$13.68b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2x |
Enterprise Value/EBITDA | 10.5x |
PEG Ratio | 1.6x |
Price to Earnings Ratio vs Peers
How does CPB *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 16.1x | ||
BIMBO A Grupo Bimbo. de | 22.3x | 18.7% | Mex$317.5b |
GRUMA B Gruma. de | 16.6x | 8.8% | Mex$123.1b |
BACHOCO B Industrias Bachoco. de | 14x | n/a | Mex$50.9b |
BAFAR B Grupo Bafar. de | 11.4x | n/a | Mex$36.3b |
CPB * Campbell Soup | 17.5x | 10.8% | Mex$13.7b |
Price-To-Earnings vs Peers: CPB * is expensive based on its Price-To-Earnings Ratio (17.5x) compared to the peer average (16.2x).
Price to Earnings Ratio vs Industry
How does CPB *'s PE Ratio compare vs other companies in the South American Food Industry?
Price-To-Earnings vs Industry: CPB * is expensive based on its Price-To-Earnings Ratio (17.5x) compared to the South American Food industry average (10.5x).
Price to Earnings Ratio vs Fair Ratio
What is CPB *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 17.5x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate CPB *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$774.00 | Mex$790.23 +2.1% | 8.4% | Mex$1,036.64 | Mex$696.76 | n/a | 21 |
Apr ’25 | n/a | Mex$774.03 0% | 8.6% | Mex$1,019.29 | Mex$685.09 | n/a | 22 |
Mar ’25 | n/a | Mex$791.50 0% | 9.9% | Mex$1,038.13 | Mex$680.74 | n/a | 20 |
Feb ’25 | Mex$760.00 | Mex$789.23 +3.8% | 10.0% | Mex$1,042.28 | Mex$683.46 | n/a | 21 |
Jan ’25 | n/a | Mex$781.08 0% | 9.5% | Mex$1,035.79 | Mex$645.24 | n/a | 20 |
Dec ’24 | n/a | Mex$791.92 0% | 10.4% | Mex$1,049.02 | Mex$653.49 | n/a | 20 |
Nov ’24 | n/a | Mex$828.96 0% | 10.1% | Mex$1,092.16 | Mex$680.36 | n/a | 20 |
Oct ’24 | n/a | Mex$816.61 0% | 9.8% | Mex$1,069.43 | Mex$718.80 | n/a | 19 |
Sep ’24 | n/a | Mex$807.09 0% | 10.0% | Mex$1,042.57 | Mex$700.74 | n/a | 18 |
Aug ’24 | n/a | Mex$850.46 0% | 8.6% | Mex$1,027.28 | Mex$707.31 | n/a | 19 |
Jul ’24 | Mex$775.00 | Mex$868.65 +12.1% | 6.9% | Mex$990.44 | Mex$734.29 | n/a | 19 |
Jun ’24 | n/a | Mex$941.41 0% | 9.0% | Mex$1,071.16 | Mex$719.96 | n/a | 18 |
May ’24 | n/a | Mex$969.78 0% | 8.9% | Mex$1,106.88 | Mex$743.97 | Mex$774.00 | 18 |
Apr ’24 | n/a | Mex$1,002.86 0% | 9.0% | Mex$1,148.22 | Mex$771.75 | n/a | 18 |
Mar ’24 | n/a | Mex$977.42 0% | 8.9% | Mex$1,129.45 | Mex$759.14 | n/a | 19 |
Feb ’24 | Mex$950.00 | Mex$996.15 +4.9% | 8.8% | Mex$1,146.51 | Mex$770.60 | Mex$760.00 | 19 |
Jan ’24 | Mex$916.29 | Mex$1,031.87 +12.6% | 9.3% | Mex$1,198.33 | Mex$766.15 | n/a | 19 |
Dec ’23 | Mex$916.29 | Mex$936.37 +2.2% | 7.2% | Mex$1,065.53 | Mex$755.55 | n/a | 18 |
Nov ’23 | Mex$916.29 | Mex$966.31 +5.5% | 7.4% | Mex$1,099.15 | Mex$779.40 | n/a | 17 |
Oct ’23 | Mex$916.29 | Mex$962.96 +5.1% | 7.7% | Mex$1,099.35 | Mex$759.55 | n/a | 17 |
Sep ’23 | n/a | Mex$968.93 0% | 7.7% | Mex$1,110.23 | Mex$767.07 | n/a | 17 |
Aug ’23 | Mex$916.29 | Mex$956.85 +4.4% | 7.8% | Mex$1,121.13 | Mex$774.60 | n/a | 17 |
Jul ’23 | Mex$916.29 | Mex$943.92 +3.0% | 6.9% | Mex$1,046.81 | Mex$764.97 | Mex$775.00 | 18 |
Jun ’23 | Mex$916.29 | Mex$897.58 -2.0% | 7.1% | Mex$1,003.76 | Mex$747.90 | n/a | 19 |
May ’23 | n/a | Mex$924.54 0% | 7.4% | Mex$1,039.91 | Mex$774.83 | n/a | 19 |
Analyst Forecast: Target price is less than 20% higher than the current share price.